Cargando…

The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia

OBJECTIVE: Pneumonia accounts for more deaths than any other infectious disease worldwide. The intestinal microbiota supports local mucosal immunity and is increasingly recognised as an important modulator of the systemic immune system. The precise role of the gut microbiota in bacterial pneumonia,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuijt, Tim J, Lankelma, Jacqueline M, Scicluna, Brendon P, de Sousa e Melo, Felipe, Roelofs, Joris J T H, de Boer, J Daan, Hoogendijk, Arjan J, de Beer, Regina, de Vos, Alex, Belzer, Clara, de Vos, Willem M, van der Poll, Tom, Wiersinga, W Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Gut Microbiota
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819612/ https://www.ncbi.nlm.nih.gov/pubmed/26511795 http://dx.doi.org/10.1136/gutjnl-2015-309728

Ejemplares similares

Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial
por: Dierikx, Thomas, et al.
Publicado: (2022)

Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
por: Schaubeck, Monika, et al.
Publicado: (2016)

Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
por: Spalinger, Marianne Rebecca, et al.
Publicado: (2022)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Antibiotics-induced monodominance of a novel gut bacterial order
por: Hildebrand, Falk, et al.
Publicado: (2019)

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
por: Le Roy, Tiphaine, et al.
Publicado: (2022)

Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
por: Tarallo, Sonia, et al.
Publicado: (2022)

Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake
por: Meslier, Victoria, et al.
Publicado: (2020)

Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery
por: Mondot, S, et al.
Publicado: (2016)

Tumour-associated and non-tumour-associated microbiota in colorectal cancer
por: Flemer, Burkhardt, et al.
Publicado: (2017)

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
por: Scott, Alasdair J, et al.
Publicado: (2019)

Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial
por: Chambers, Edward S, et al.
Publicado: (2019)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
por: Lavelle, A, et al.
Publicado: (2015)

No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population
por: Hugerth, Luisa W, et al.
Publicado: (2020)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
por: Bolte, Laura A, et al.
Publicado: (2021)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer
por: Liang, Jessie Qiaoyi, et al.
Publicado: (2020)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2013)

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
por: Chambers, Edward S, et al.
Publicado: (2015)

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
por: Serino, Matteo, et al.
Publicado: (2011)

Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88
por: Larsson, Erik, et al.
Publicado: (2011)

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
por: Manichanh, Chaysavanh, et al.
Publicado: (2014)

Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
por: Vandeputte, Doris, et al.
Publicado: (2016)

Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect
por: Wang, Xingmin, et al.
Publicado: (2015)

Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016)

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
por: Sabino, João, et al.
Publicado: (2016)

Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
por: Catry, Emilie, et al.
Publicado: (2018)

Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens
por: Cabinian, Allison, et al.
Publicado: (2018)

Changes in the gut microbiota composition and the plasma ghrelin level in patients with Helicobacter pylori-infected patients with eradication therapy
por: Yanagi, Hidetaka, et al.
Publicado: (2017)

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
por: Vandeputte, Doris, et al.
Publicado: (2017)

Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus
por: Wang, Jinfeng, et al.
Publicado: (2018)

Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice
por: Wu, Wei-Kai, et al.
Publicado: (2019)

Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota
por: Tito, Raul Y, et al.
Publicado: (2019)

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
por: Ren, Zhigang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ebt56l9vst69kp9k44v159atv